全文获取类型
收费全文 | 29788篇 |
免费 | 105篇 |
国内免费 | 118篇 |
专业分类
系统科学 | 195篇 |
丛书文集 | 470篇 |
教育与普及 | 41篇 |
理论与方法论 | 95篇 |
现状及发展 | 13288篇 |
研究方法 | 1309篇 |
综合类 | 14115篇 |
自然研究 | 498篇 |
出版年
2013年 | 225篇 |
2012年 | 444篇 |
2011年 | 931篇 |
2010年 | 185篇 |
2008年 | 530篇 |
2007年 | 625篇 |
2006年 | 562篇 |
2005年 | 603篇 |
2004年 | 662篇 |
2003年 | 528篇 |
2002年 | 567篇 |
2001年 | 913篇 |
2000年 | 860篇 |
1999年 | 613篇 |
1992年 | 622篇 |
1991年 | 424篇 |
1990年 | 450篇 |
1989年 | 429篇 |
1988年 | 420篇 |
1987年 | 439篇 |
1986年 | 487篇 |
1985年 | 614篇 |
1984年 | 450篇 |
1983年 | 356篇 |
1982年 | 319篇 |
1981年 | 338篇 |
1980年 | 399篇 |
1979年 | 938篇 |
1978年 | 724篇 |
1977年 | 708篇 |
1976年 | 553篇 |
1975年 | 551篇 |
1974年 | 847篇 |
1973年 | 702篇 |
1972年 | 760篇 |
1971年 | 824篇 |
1970年 | 1156篇 |
1969年 | 916篇 |
1968年 | 812篇 |
1967年 | 832篇 |
1966年 | 790篇 |
1965年 | 577篇 |
1964年 | 204篇 |
1959年 | 288篇 |
1958年 | 563篇 |
1957年 | 396篇 |
1956年 | 318篇 |
1955年 | 285篇 |
1954年 | 313篇 |
1948年 | 214篇 |
排序方式: 共有10000条查询结果,搜索用时 125 毫秒
501.
辣根过氧化物酶处理五氯酚过程的毒性特征 总被引:3,自引:0,他引:3
用酶的催化聚合作用来处理酚类及芳香胺类化合物的污染是近年来受到重视的新方法,但人们很少研究废水在这一处理过程中的毒性变化。采用辣根过氧化物酶和过氧化氢在pH值为4时处理含五氯酚的模拟废水,集中研究了该过程的发光菌毒性特性。结果表明,五氯酚溶液的毒性在处理后大为降低,总毒性可降低至起始毒性的15%左右。处理过程的产物有少量溶解在水中,也构成一部分毒性。 相似文献
502.
The role of hypoxia-inducible factors in cancer 总被引:7,自引:0,他引:7
503.
Advances in our understanding of cardiac development have fuelled research into cellular approaches to myocardial repair of
the damaged heart. In this collection of reviews we present recent advances into the basic mechanisms of heart development
and the resident and non-resident progenitor cell populations that are currently being investigated as potential mediators
of cardiac repair. Together these reviews illustrate that despite our current knowledge about how the heart is constructed,
caution and much more research in this exciting field is essential. The current momentum to evaluate the potential for cardiac
repair will in turn accelerate research into fundamental aspects of myocardial biology. 相似文献
504.
Aldose reductase and aldehyde reductase belong to the aldo-keto reductase superfamily of enzymes whose members are responsible
for a wide variety of biological functions. Aldose reductase has been identified as the first enzyme involved in the polyol
pathway of glucose metabolism which converts glucose into sorbitol. Glucose over-utilization through the polyol pathway has
been linked to tissue-based pathologies associated with diabetes complications, which make the development of a potent aldose
reductase inhibitor an obvious and attractive strategy to prevent or delay the onset and progression of the complications.
Structural studies of aldose reductase and the homologous aldehyde reductase in complex with inhibitor were carried out to
explain the difference in the potency of enzyme inhibition. The aim of this review is to provide a comprehensive summary of
previous studies to aid the development of aldose reductase inhibitors that may have less toxicity problems than the currently
available ones.
Received 4 December 2006; received after revision 12 February 2007; accepted 20 April 2007 相似文献
505.
Modulation of protein biophysical properties by chemical glycosylation: biochemical insights and biomedical implications 总被引:2,自引:0,他引:2
Solá RJ Rodríguez-Martínez JA Griebenow K 《Cellular and molecular life sciences : CMLS》2007,64(16):2133-2152
Glycosylation constitutes one of the most important posttranslational modifications employed by biological systems to modulate
protein biophysical properties. Due to the direct biochemical and biomedical implications of achieving control over protein
stability and function by chemical means, there has been great interest in recent years towards the development of chemical
strategies for protein glycosylation. Since current knowledge about glycoprotein biophysics has been mainly derived from the
study of naturally glycosylated proteins, chemical glycosylation provides novel insights into its mechanistic understanding
by affording control over glycosylation parameters. This review presents a survey of the effects that natural and chemical
glycosylation have on the fundamental biophysical properties of proteins (structure, dynamics, stability, and function). This
is complemented by a mechanistic discussion of how glycans achieve such effects and discussion of the implications of employing
chemical glycosylation as a tool to exert control over protein biophysical properties within biochemical and biomedical applications.
Received 15 December 2006; received after revision 28 March 2007; accepted 25 April 2007 相似文献
506.
Komen JC Distelmaier F Koopman WJ Wanders RJ Smeitink J Willems PH 《Cellular and molecular life sciences : CMLS》2007,64(24):3271-3281
Refsum disease is a rare, inherited neurodegenerative disorder characterized by accumulation of the dietary branched-chain
fatty acid phytanic acid in plasma and tissues caused by a defect in the alphaoxidation pathway. The accumulation of phytanic
acid is believed to be the main pathophysiological cause of the disease. However, the exact mechanism(s) by which phytanic
acid exerts its toxicity have not been resolved. In this study, the effect of phytanic acid on mitochondrial respiration was
investigated. The results show that in digitonin-permeabilized fibroblasts, phytanic acid decreases ATP synthesis, whereas
substrate oxidation per se is not affected. Importantly, studies in intact fibroblasts revealed that phytanic acid decreases both the mitochondrial
membrane potential and NAD(P)H autofluorescence. Taken together, the results described here show that unesterified phytanic
acid exerts its toxic effect mainly through its protonophoric action, at least in human skin fibroblasts.
Received 4 August 2007; received after revision 26 September 2007; accepted 10 October 2007
J. C. Komen, F. Distelmaier: These authors contributed equally to this work. 相似文献
507.
Dhar-Chowdhury P Malester B Rajacic P Coetzee WA 《Cellular and molecular life sciences : CMLS》2007,64(23):3069-3083
Glycolysis is an evolutionary conserved metabolic pathway that provides small amounts of energy in the form of ATP when compared
to other pathways such as oxidative phosphorylation or fatty acid oxidation. The ATP levels inside metabolically active cells
are not constant and the local ATP level will depend on the site of production as well as the respective rates of ATP production,
diffusion and consumption. Membrane ion transporters (pumps, exchangers and channels) are located at sites distal to the major
sources of ATP formation (the mitochondria). We review evidence that the glycolytic complex is associated with membranes;
both at the plasmalemma and with membranes of the endo/sarcoplasmic reticular network. We examine the evidence for the concept
that many of the ion transporters are regulated preferentially by the glycolytic process. These include the Na+/K+-ATPase, the H+-ATPase, various types of Ca2+-ATPases, the Na+/H+ exchanger, the ATP-sensitive K+ channel, cation channels, Na+ channels, Ca2+ channels and other channels involved in intracellular Ca2+ homeostasis. Regulation of these pumps, exchangers and ion channels by the glycolytic process has important consequences
in a variety of physiological and pathophysiological processes, and a better understanding of this mode of regulation may
have important consequences for developing future strategies in combating disease and developing novel therapeutic approaches.
Received 20 July 2007; received after revision 30 July 2007; accepted 17 August 2007 相似文献
508.
Edouard T Montagner A Dance M Conte F Yart A Parfait B Tauber M Salles JP Raynal P 《Cellular and molecular life sciences : CMLS》2007,64(13):1585-1590
Activating and inactivating mutations of SHP-2 are responsible, respectively, for the Noonan (NS) and the LEOPARD (LS) syndromes.
Clinically, these developmental disorders overlap greatly, resulting in the apparent paradox of similar diseases caused by
mutations that oppositely influence SHP-2 phosphatase activity. While the mechanisms remain unclear, recent functional analysis
of SHP-2, along with the identification of other genes involved in NS and in other related syndromes (neurofibromatosis-1,
Costello and cardio-facio-cutaneous syndromes), strongly suggest that Ras/MAPK represents the major signaling pathway deregulated
by SHP-2 mutants. We discuss the idea that, with the exception of LS mutations that have been shown to exert a dominant negative
effect, all disease-causing mutations involved in Ras/MAPK-mediated signaling, including SHP-2, might lead to enhanced MAPK
activation. This suggests that a narrow range of MAPK signaling is required for appropriate development. We also discuss the
possibility that LS mutations may not simply exhibit dominant negative activity.
Received 30 November 2006; received after revision 8 February 2007; accepted 13 March 2007 相似文献
509.
510.